Chapter Category: Channels and Transporters

From the book The Cystic Fibrosis Transmembrane Conductance Regulator

Pharmacology of ΔF508-CFTR Biosynthesis

Robert Bridges

The search for compounds to rescue the biosynthesis of DF508-CFTR has become a major goal of the Cystic Fibrosis research community. The Cystic Fibrosis Foundation has partnered with several pharmaceutical companies in an effort to achieve this goal. Hundreds of thousands of compounds have already been tested in primary screening assays designed to discover compounds that will rescue the biosynthesis of DF508-CFTR as well as compounds that will improve the dysfunctional channel properties. In this review I discuss the problems to be solved concerning the rescue of DF508-CFTR biosynthesis and its restoration to normal CFTR channel function. I then present the preclinical studies one should perform to evaluate the efficacy of a candidate compound to rescue the biosynthesis of DF508-CFTR. Finally, I present the status of those compounds under evaluation for the treatment of cystic fibrosis in the context of these required preclinical studies.


Taken from the book

The Cystic Fibrosis Transmembrane Conductance Regulator

Edited by: Kevin Kirk and David C. Dawson

More chapters from the book:

The CFTR Gene and Genetics of Cystic Fibrosis
Rebecca Rowntree and Ann Harris

Cystic Fibrosis (CF) is an autosomal recessive disorder caused by mutations in the CFTR gene. The CFTR gene, located on chromosome 7q31, was identified in 1989. Genomic DNA probes from the chromosomal region (DNA sequences that showed high homology across species) were used to screen a cDNA...


Anion Conduction by CFTR: Mechanisms and Models
David C. Dawson, Xuehong Liu, Zhi-Ren Zhang and Nael McCarty

In the more than 10 years that have elapsed since the identification by positional cloning of the cystic fibrosis gene, 1-3 the gene product, the cystic fibrosis transmembrane conductance regulator (CFTR), has been implicated in a variety of functional roles in cells. 4-10 Of these,...


Phosphatase Regulation of CFTR
John W. Hanrahan, Tang Zhu and L. Daniel Howell

The cystic fibrosis transmembrane conductance regulator (CFTR) chloride channel is tightly regulated by the opposing actions of protein kinases and phosphatases. Its phosphorylation and activation by protein kinases A (PKA) and C (PKC) have been studied in some detail but phosphatase...


In epithelial tissues of cystic fibrosis patients, the secretory Cl- transport is impaired, while the absorptive Na + transport is enhanced. The disease causing cystic fibrosis transmembrane conductance regulator (CFTR) is a protein expressed primarily in luminal membranes of secretory and...


CFTR Interacting Proteins
Estelle Cormet-Boyaka, Anjaparavanda P. Naren and Kevin Kirk

The Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) controls salt and water transport across epithelial tissues. CFTR serves this role primarily by functioning as a cyclic AMP-activated chloride channel at the lumen-facing, or apical, membranes of epithelial cells that line the...


The major pulmonary pathology of cystic fibrosis (CF) is caused by colonization of the airways with Pseudomonas aeruginosa and other bacteria. The airways are lined with a thin film of liquid, the airway surface liquid ( ASL), that in health is ~10 μm deep. How does reduced CFTR function...


Inflammatory Responses in the Cystic Fibrosis Lung
James Chmiel and Pamela B. Davis

The lung disease of cystic fibrosis (CF) is characterized by a self-sustaining cycle of airway obstruction, infection and inflammation that accounts for the majority of morbidity and mortality. Bacteria in the CF airway incite a vigorous inflammatory response that is more pernicious than...


Gene Therapy for Cystic Fibrosis
Kimberly V. Curlee and Eric J. Sorscher

The precise functional defects and mechanisms linking mutations in CFTR to disease phenotype are not well understood. Although CFTR serves as a cAMP activated Clchannel, it has also been implicated in other cellular processes including regulation of ion transport (e.g., through the epithelial...


The search for compounds to rescue the biosynthesis of DF508-CFTR has become a major goal of the Cystic Fibrosis research community. The Cystic Fibrosis Foundation has partnered with several pharmaceutical companies in an effort to achieve this goal. Hundreds of thousands of compounds have...


Advertisements